Los Angeles, CA – August 28, 2018 — Worldwide Business with kathy ireland® is pleased to announce an exclusive interview with Diaceutics CEO Peter Keeling and Managing Director Steve Vitale to discuss how they are driving better testing to enable better treatment decisions for patients through their expertise in diagnostic services.
Diaceutics works with pharmaceutical companies and laboratories, providing an end-to-end service to help more patients get the treatment they need at the time they need it.
“Many of us will have friends or family who will be diagnosed with cancer and many times it is a very emotional rollercoaster,” says Keeling. ”Lung cancer could take up to three years to get diagnosed – Alzheimer’s up to seven. Some problems we see are that patients may not get the right test; the test isn’t reimbursed or the doctor may not know what test is needed. We can help overcome these issues.”
“Diaceutics provides a high quality, consistent, and patient-centered approach,” says Vitale. “Our method is to identify what hurdles might occur along the diagnostic journey and to apply a systematic way to analyze data and help customers implement better testing worldwide.”
As the global market leader and operating in the top percentile of high growth companies, Diaceutics is revolutionizing patient testing. It offers an end-to-end service in the world’s top 10 markets, covering everything from pinpointing patients who should be taking specific drugs, to mapping the diagnostic ecosystem so that customers know where testing is taking place, to integrating testing into treatment pathways.
The company has completed over 300 diagnostic projects, and currently works with 31 out of the world’s 35 biggest pharmaceutical companies, providing specialized expertise via differentiated, proprietary services. Its growth potential is huge, as the precision medicine marketplace is expected to multiply five times in the next 5 years because of the new medicines due to come to market.
Half a million patients have already benefitted because Diaceutics is bridging the gap between doctors, labs and pharmaceutical companies.
“This is truly a life-saving concept and we are looking forward to sharing the story of Diaceutics on our show,” says D.L. Haber, Vice President of Programming for Worldwide Business.
For more information about Diaceutics, visit diaceutics.com and tune in to Fox Business Network as sponsored content on Sunday, September 2, 2018 at 5:30pm EST and Bloomberg International on Saturday, September 1, 2018 at 7:30pm GMT and Sunday, September 2, 2018 at 10:30am D.F. and 3:00pm HKT.
About Worldwide Business with kathy ireland®
Worldwide Business with kathy ireland® is a weekly half-hour show featuring global executives sharing their business insights and framing the opportunities shaping their industries. Hosted by a business mogul, Kathy Ireland interviews some of the brightest minds in business today. The show broadcasts on Fox Business Network as part of their sponsored content line up and globally on Bloomberg International. Worldwide Business with kathy ireland® extends beyond the weekly on-air program with digital content delivered on various video platforms and across social media.
Visit www.tvwwb.com for detailed airing schedules or check local listings.
Diaceutics is a diagnostic development and commercialization service provider. It has been leading its field for 13 years, entirely focused on the intersection between diagnostics and therapeutic decision making. The company provides an end to end service that encompasses everything from understanding the diagnostic landscape to test implementation in treatment pathways. This is all enabled by a robust flow of data from the Diaceutics global laboratory network. Their ultimate goal is to drive better testing to enable better treatment decisions for patients. www.diaceutics.com
Fast facts about Diaceutics:
- Proven global market leader with experience of 300+ precision medicine project
- Has helped launch 6 out of the last 12 targeted oncology brands
- Extensive coverage of Top 10 global markets: US, France, Germany, UK, Italy, Spain, Brazil, China, Russia, Australia
- Estimates indicate having improved testing for over 500,000 patients globally
- Draw data from a global network of over 2,900 laboratories to facilitate diagnostic insights
Employs a leading global group of experts from the laboratory, diagnostic and pharmaceutical industries
Company Name: Worldwide Business with kathy ireland®
Contact Person: Gila Stern | Communications Director
Email: Send Email
Phone: 561-325-7700 x529
Country: United States